Iressa 250 mg Tablet

Iressa 250 mg Tablet contains gefitinib, a targeted anticancer medicine used to treat certain types of non-small cell lung cancer. Each tablet contains 250 mg of gefitinib and is taken orally as prescribed by a specialist. It works by blocking EGFR signaling involved in the growth of certain lung cancer cells.

BUY NOW

Category AstraZeneca Pharma India Ltd

Description

Gefitinib is an EGFR tyrosine kinase inhibitor that targets specific activating EGFR mutations in eligible patients with non-small cell lung cancer. By inhibiting abnormal EGFR signaling, it can help slow the growth and spread of cancer cells. Iressa is generally used as monotherapy in adults with locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations. Treatment should be initiated and supervised by a physician experienced in anticancer therapy.

Technical Specification

Specification	Details
Active Ingredient	Gefitinib
Strength	250 mg
Dosage Form	Film-Coated Tablet
Route of Administration	Oral
Pack Size	30 Tablets
Manufacturer/Marketer	AstraZeneca Pharma India Ltd

Product Also Known As

Iressa 250 mg Tablet, Gefitinib 250 mg Tablet, Iressa Gefitinib Tablet, Gefitinib Anticancer Tablet, EGFR Inhibitor Tablet, Non-Small Cell Lung Cancer Treatment Tablet

Iressa 250 mg Tablet

Technical Specification

Product Also Known As

Tagrisso 80 mg Tablet

Nolvadex 10 mg Tablet